Phase III trial of meldonium (Mildronate) in China in patients with heart failure or ischaemic heart disorders.

Trial Profile

Phase III trial of meldonium (Mildronate) in China in patients with heart failure or ischaemic heart disorders.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Dec 2014

At a glance

  • Drugs Meldonium (Primary)
  • Indications Heart failure; Ischaemic heart disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Grindeks
  • Most Recent Events

    • 03 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top